Home Biosimilar Antibodies Transmembrane Transporters CD markers Tremelimumab (anti-CTLA-4) For research use only.
Not for use in humans.

Tremelimumab (anti-CTLA-4)

Synonyms: Ticilimumab, CP-675,206

Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.

Tremelimumab (anti-CTLA-4)

Purity & Quality Control

Batch: Purity: 99.87% Protein concentration: 8.05mg/ml Endotoxin Level: <1 EU/mg
99.87

Choose Selective CD markers Inhibitors

Biological Activity

Description Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.

Product Details

CAS No. 745013-59-6
Molecular Weight 146.4 kDa
Isotype Human IgG2
Source HEK293 Cells
Purification Protein G
Sterility 0.2 μM filtered
Formulation PBS Buffer, PH 7.4
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tremelimumab (anti-CTLA-4) | Tremelimumab (anti-CTLA-4) supplier | purchase Tremelimumab (anti-CTLA-4) | Tremelimumab (anti-CTLA-4) cost | Tremelimumab (anti-CTLA-4) manufacturer | order Tremelimumab (anti-CTLA-4) | Tremelimumab (anti-CTLA-4) distributor